|
1
|
Ruggenenti P, Cravedi P and Remuzzi G:
Mechanisms and treatment of CKD. J Am Soc Nephrol. 23:1917–1928.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stenvinkel P, Ketteler M, Johnson RJ, et
al: IL-10, IL-6, and TNF-alpha: central factors in the altered
cytokine network of uremia - the good, the bad, and the ugly.
Kidney Int. 67:1216–1233. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abbate M, Zoja C and Remuzzi G: How does
proteinuria cause progressive renal damage? J Am Soc Nephrol.
17:2974–2984. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cachofeiro V, Goicochea M, de Vinuesa SG,
Oubina P, Lahera V and Luno J: Oxidative stress and inflammation, a
link between chronic kidney disease and cardiovascular disease.
Kidney Int Suppl. S4–S9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yi F, Xia M, Li N, Zhang C, Tang L and Li
PL: Contribution of guanine nucleotide exchange factor Vav2 to
hyperhomocysteinemic glomerulosclerosis in rats. Hypertension.
53:90–96. 2009. View Article : Google Scholar :
|
|
6
|
Tian N, Thrasher KD, Gundy PD, Hughson MD
and Manning RD Jr: Antioxidant treatment prevents renal damage and
dysfunction and reduces arterial pressure in salt-sensitive
hypertension. Hypertension. 45:934–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meng X, Zhang K, Li J, et al: Statins
induce the accumulation of regulatory T cells in atherosclerotic
plaque. Mol Med. 18:598–605. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Athyros VG, Papageorgiou AA, Elisaf M and
Mikhailidis DP: Statins and renal function in patients with
diabetes mellitus. Curr Med Res Opin. 19:615–617. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Imaizumi T, Aizawa-Yashiro T, Tsuruga K,
et al: Melanoma differentiation-associated gene 5 regulates the
expression of a chemokine CXCL10 in human mesangial cells:
implications for chronic inflammatory renal diseases. Tohoku J Exp
Med. 228:17–26. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schlondorff D and Banas B: The mesangial
cell revisited: no cell is an island. J Am Soc Nephrol.
20:1179–1187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruiz-Ortega M, Ruperez M, Lorenzo O, et
al: Angiotensin II regulates the synthesis of proinflammatory
cytokines and chemokines in the kidney. Kidney Int. 62:S12–S22.
2002. View Article : Google Scholar
|
|
12
|
Zhong J, Guo D, Chen CB, et al: Prevention
of angiotensin II-mediated renal oxidative stress, inflammation,
and fibrosis by angiotensin-converting enzyme 2. Hypertension.
57:314–322. 2011. View Article : Google Scholar
|
|
13
|
Thallas-Bonke V, Thorpe SR, Coughlan MT,
et al: Inhibition of NADPH oxidase prevents advanced glycation end
product-mediated damage in diabetic nephropathy through a protein
kinase C-alpha-dependent pathway. Diabetes. 57:460–469. 2008.
View Article : Google Scholar
|
|
14
|
Kitada M, Koya D, Sugimoto T, et al:
Translocation of glomerular p47phox and p67phox by protein kinase
C-beta activation is required for oxidative stress in diabetic
nephropathy. Diabetes. 52:2603–2614. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kintscher U, Lyon CJ and Law RE:
Angiotensin II, PPAR-gamma and atherosclerosis. Front Biosci.
9:359–369. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pearse DD, Tian RX, Nigro J, Iorgulescu
JB, Puzis L and Jaimes EA: Angiotensin II increases the expression
of the transcription factor ETS-1 in mesangial cells. Am J Physiol
Renal Physiol. 294:F1094–F1100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Varghese Z, Fernando R, Moorhead JF, Powis
SH and Ruan XZ: Effects of sirolimus on mesangial cell cholesterol
homeostasis: a novel mechanism for its action against
lipid-mediated injury in renal allografts. Am J Physiol Renal
Physiol. 289:F43–F48. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stenvinkel P, Heimburger O, Paultre F, et
al: Strong association between malnutrition, inflammation, and
atherosclerosis in chronic renal failure. Kidney Int. 55:1899–1911.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pawluczyk IZ, Tan EK and Harris KP: Rat
mesangial cells exhibit sex-specific profibrotic and
proinflammatory phenotypes. Nephrol Dial Transplant. 24:1753–1758.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang M, Gao X, Wu J, et al: Oxidized
high-density lipoprotein enhances inflammatory activity in rat
mesangial cells. Diabetes Metab Res Rev. 26:455–463. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Theuer J, Dechend R, Muller DN, et al:
Angiotensin II induced inflammation in the kidney and in the heart
of double transgenic rats. BMC Cardiovasc Disord. 2:32002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Presti RL, Carollo C and Caimi G: Wine
consumption and renal diseases: new perspectives. Nutrition.
23:598–602. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li JM and Shah AM: ROS generation by
nonphagocytic NADPH oxidase: potential relevance in diabetic
nephropathy. J Am Soc Nephrol. 14:S221–S226. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jaimes EA, Galceran JM and Raij L:
Angiotensin II induces superoxide anion production by mesangial
cells. Kidney Int. 54:775–784. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang C, Ting AT and Seed B: PPAR-gamma
agonists inhibit production of monocyte inflammatory cytokines.
Nature. 391:82–86. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu X and Li L: Rosiglitazone suppresses
lipopolysaccharide-induced matrix metalloproteinase-2 activity in
rat aortic endothelial cells via Ras-MEK1/2 signaling. Int J
Cardiol. 158:54–58. 2012. View Article : Google Scholar
|
|
27
|
Asano T, Wakisaka M, Yoshinari M, et al:
Peroxisome proliferator-activated receptor gamma1 (PPARgamma1)
expresses in rat mesangial cells and PPARgamma agonists modulate
its differentiation. Biochim Biophys Acta. 1497:148–154. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rangan G, Wang Y and Harris D: NF-kappaB
signalling in chronic kidney disease. Front Biosci (Landmark Ed).
14:3496–3522. 2009. View
Article : Google Scholar
|
|
29
|
Wang Y, Zhang MX, Meng X, et al:
Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like
receptor 4 and its signaling pathway in endothelial cells. Am J
Physiol Heart Circ Physiol. 300:H1743–H1752. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zahner G, Schaper M, Panzer U, et al:
Prostaglandin EP2 and EP4 receptors modulate expression of the
chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular
inflammation. Biochem J. 422:563–570. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang L, Pang S, Deng B, et al: High
glucose induces renal mesangial cell proliferation and fibronectin
expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is
inhibited by resveratrol. Int J Biochem Cell Biol. 44:629–638.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang F, Zhang Y and Dusting GJ: NADPH
oxidase-mediated redox signaling: roles in cellular stress
response, stress tolerance, and tissue repair. Pharmacol Rev.
63:218–242. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oudit GY, Liu GC, Zhong J, et al: Human
recombinant ACE2 reduces the progression of diabetic nephropathy.
Diabetes. 59:529–538. 2010. View Article : Google Scholar :
|
|
34
|
Korchak HM and Kilpatrick LE: Roles for
beta II-protein kinase C and RACK1 in positive and negative
signaling for superoxide anion generation in differentiated HL60
cells. J Biol Chem. 276:8910–8917. 2001. View Article : Google Scholar
|
|
35
|
Wei XF, Zhou QG, Hou FF, Liu BY and Liang
M: Advanced oxidation protein products induce mesangial cell
perturbation through PKC-dependent activation of NADPH oxidase. Am
J Physiol Renal Physiol. 296:F427–F437. 2009. View Article : Google Scholar
|
